NCT02035371 A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT02034513 A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT02033239 A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT02030600 A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02022254 Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02016911 Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT02014259 Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function Status COMPLETED Phase PHASE1
NCT02008682 The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT02005198 Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD) Status COMPLETED Phase N/A
NCT02003677 A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01999322 A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01992588 A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01988532 Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia Status COMPLETED Phase N/A
NCT01984372 Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba® Status COMPLETED Phase N/A
NCT01978613 Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01973244 A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency Status COMPLETED Phase PHASE1
NCT01973231 Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01967589 Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01959555 Project to Update the Study of Congenital Haemophilia in Spain Status COMPLETED Phase N/A
NCT01959529 A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events Status COMPLETED Phase PHASE3